Paulson & Co. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$86,323,000
-58.0%
4,727,415
-58.1%
1.98%
-62.9%
Q4 2020$205,584,000
+2.0%
11,295,8460.0%5.34%
-15.0%
Q3 2020$201,518,000
-2.2%
11,295,846
-1.7%
6.28%
-4.6%
Q2 2020$205,960,000
+2.4%
11,486,905
-13.3%
6.58%
-14.2%
Q1 2020$201,055,000
-23.1%
13,244,7110.0%7.67%
+36.0%
Q4 2019$261,318,000
+14.7%
13,244,7110.0%5.64%
+23.7%
Q3 2019$227,809,000
-2.8%
13,244,7110.0%4.56%
+14.5%
Q2 2019$234,431,000
-56.6%
13,244,711
-50.0%
3.98%
-30.9%
Q1 2019$539,590,00026,489,4225.77%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders